President and CEO Alison Moore outlined the company’s strategic focus on RNA medicines manufacturing at TD Cowen’s 46th ...
A team at ETH Zurich developed a new peptide-based organocatalyst that handles macrocycle formation from start to finish.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results